Health · Medical Research · 10 hrs ago
Chinese team develops blood purifier to remove circulating tumour cells
A Chinese research team has developed a blood-purifying device designed to remove tumour cells that break away and circulate in the bloodstream.
The platform was developed by a team led by Shanghai Jiao Tong University and is described as a proof of concept.
These circulating cells can help cancer spread to other parts of the body, a process called metastasis.
In tests on mice with breast cancer, the device removed circulating tumour cells.
The tests found that tumour relapse was delayed and survival extended.
The results are early evidence from animal tests, and the research does not establish whether the device works in people.
Chinese scientists have developed a purifier designed to remove circulating tumour cells from the bloodstream.
The Shanghai Jiao Tong University-led team said the proof-of-concept platform could lower the risk of metastasis.
In mouse models of breast cancer, the device removed breakaway tumour cells, delayed tumour relapse and extended survival.
The findings were published in Microsystems & Nanoengineering on November 2.
- Who
- A team led by Shanghai Jiao Tong University scientists.
- What
- They developed a proof-of-concept purifier to remove circulating tumour cells from blood.
- When
- The research paper was published on November 2. The article was published on November 9, 2026.
- Where
- In China; testing was conducted in mouse models of breast cancer. The article does not state where the tests took place.
- Why
- The platform could lower the risk of metastasis and potentially help prevent cancer recurrence and spread.
This story does not have two clearly opposing sides.
The research paper on the purifier was published in Microsystems & Nanoengineering.
SCMP published its report on the Chinese team’s purifier.
- Research team
- Led by Shanghai Jiao Tong University
- Target
- Circulating tumour cells in the bloodstream
- Test model
- Mice with breast cancer
- Reported effects
- Delayed tumour relapse and extended survival
- Journal
- Microsystems & Nanoengineering